Welcome to our dedicated page for Megola news (Ticker: MGON), a resource for investors and traders seeking the latest updates and insights on Megola stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Megola's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Megola's position in the market.
Megola Inc. (MGON) has reported significant operational updates as of Q3 2020, with notable achievements including the full payment of $70,000 cash debt linked to 470 Systems and another $20,000 from 454 CBD units. The company is focusing on expanding its product lines, which include antimicrobial products and specialty coffees, projecting gross profits exceeding $100,000 from recent acquisitions. Megola also exited shell status in October 2020, which may enable a transition to a higher OTC tier.
Megola, Inc. (OTC PINK:MGON) is entering the expanding CBD market with its Balanced2Day brand, offering premium hemp extract products aimed at enhancing wellness and performance. These products are non-GMO, gluten-free, and available in various forms, including tinctures and lotions. The CBD market is projected to grow significantly, with a CAGR of 52.7% through 2026, driven by increasing consumer awareness of CBD's health benefits. Megola emphasizes transparency with third-party testing for quality assurance and compliance with US regulations.
Summary not available.
Megola Inc. (MGON) announces key changes, including the appointment of Bob Gardiner as CEO, bringing over 27 years of experience in business development and acquisitions. The new Board of Directors comprises seasoned professionals to enhance leadership. Megola has finalized acquisitions of innovative products: the Stink Genie, a disinfectant system effective against pathogens like SARS Coronavirus, and the Balanced2day CBD product line aimed at athletes. The company plans to rebrand as MEGOLA across all platforms amid COVID-related delays.